Tower View Investment Management & Research LLC Abb Vie Inc. Transaction History

Tower View Investment Management & Research LLC

$173 Million
Q3 2024

A detailed history of Tower View Investment Management & Research LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tower View Investment Management & Research LLC holds 1,008 shares of ABBV stock, worth $176,984. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,008

Previous 1,004 0.4%

Holding current value

$176,984

Previous $172,000 15.7%

% of portfolio

0.12%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $655 - $797	4 Added 0.4%	1,008 $199,000
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $619 - $723	4 Added 0.4%	1,004 $172,000
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $43,630 - $49,713	-273 Reduced 21.45%	1,000 $182,000
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $15,686 - $17,666	-114 Reduced 8.22%	1,273 $197,000
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $72,272 - $83,665	541 Added 63.95%	1,387 $207,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $26,104 - $32,485	197 Added 30.35%	846 $114,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1,590 - $1,831	-11 Reduced 1.67%	649 $103,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3,181 - $3,815	-23 Reduced 3.37%	660 $107,000
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $11,273 - $12,930	84 Added 14.02%	683 $92,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $131 - $163	1 Added 0.17%	599 $97,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $107 - $135	1 Added 0.17%	598 $81,000
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $45,964 - $52,176	432 Added 261.82%	597 $64,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $2,419 - $2,695	-23 Reduced 12.23%	165 $19,000
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $23,529 - $25,902	-230 Reduced 55.02%	188 $20,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $10,785 - $14,561	134 Added 47.18%	418 $45,000
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 1.07%	284 $25,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $513 - $687	7 Added 2.55%	281 $28,000
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $216 - $270	3 Added 1.11%	274 $24,000
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $314 - $378	5 Added 1.88%	271 $20,000
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $197 - $251	3 Added 1.14%	266 $19,000
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $308 - $363	4 Added 1.54%	263 $21,000
Q4 2018 Jan 04, 2019	BUY	$77.85 - $96.01 $233 - $288	3 Added 1.17%	259 $24,000
Q3 2018 Oct 12, 2018	SELL	$88.91 - $98.84 $4,089 - $4,546	-46 Reduced 15.23%	256 $24,000
Q2 2018 Jul 23, 2018	BUY	$89.78 - $106.23 $269 - $318	3 Added 1.0%	302 $28,000
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $92 - $123	1 Added 0.34%	299 $28,000
Q4 2017 Jan 24, 2018	BUY	$89.56 - $98.21 $26,688 - $29,266	298	298 $29,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.

Account

Tower View Investment Management & Research LLC Abb Vie Inc. Transaction History